ghk-cu peptide uses benefits GHK-Cu Peptide: Benefits, Dosing &

U S A 94, 54015404

Unlike BPC-157 (which has zero registered US trials), tesamorelin has an extensive clinical trial history supporting its FDA-approved status

The skin-specific mechanisms of GHK-Cu include stimulation of Type I and Type III procollagen synthesis, increased production of dermatan sulfate and other glycosaminoglycans, activation of the enzyme lysyl oxidase (which cross-links newly formed collagen), reduction of matrix metalloproteinase-1 (MMP-1, collagenase) activity, and anti-inflammatory suppression of TNF-alpha-induced IL-6 secretion

Research shows that NAD+ levels decline with age, making it a key factor in how we age and a promising target for age-related interventions